Short-term intratracheal use of PEG-modified IL-2 and glucocorticoid persistently alleviates asthma in a mouse model.PDF

Short-term intratracheal use of PEG-modified IL-2 and glucocorticoid persistently alleviates asthma in a mouse model.PDF

Short-term intratracheal use of PEG-modified IL-2 and glucocorticoid persistently alleviates asthma in a mouse model

/scientificreports OPEN Short-term intratracheal use of PEG-modified IL-2 and glucocorticoid persistently Received: 14 April 2016 alleviates asthma in a mouse model accepted: 22 July 2016 Published: 16 August 2016 1,* 1,* 2 2 1 3 2 Kefe

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档